Given that SHC4 does not involve major alterations in the properties of human bone marrow mesenchymal cells, it is a promising candidate for studying MDS caused by other genetic abnormalities, such as DICER1, in human mesenchymal cells. This evidence concerns the gene SHC4 and myelodysplastic syndrome.